Publications | Cervo Brain Research Centre

Export 15 results:

Filters: Author is Bouchard, Roch-Hugo [Clear All Filters]

2016

Cellard C, Reeder C, Paradis-Giroux A-A, M-A Roy, Gilbert E, Ivers H, Bouchard R-H, Maziade M, Wykes T. A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia. Neuropsychol Rehabil. 2016;26(3):321-44.

Paccalet T, Gilbert E, Berthelot N, Marquet P, Jomphe V, Lussier D, Bouchard R-H, Cliche D, Gingras N, Maziade M. Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder. Schizophr Res. 2016;175(1-3):186-192.

2015

M-A Roy, Achim A, Vallières C, Labbé A, Mérette C, Maziade M, Demers M-F, Bouchard R-H. Comorbidity between anxiety disorders and recent-onset psychotic disorders. Schizophr Res. 2015;166(1-3):353-4.

2014

Gilbert E, Mérette C, Jomphe V, Emond C, Rouleau N, Bouchard R-H, M-A Roy, Paccalet T, Maziade M. Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment. Eur Arch Psychiatry Clin Neurosci. 2014;264(4):333-43.

2010

Poirier S, Legris G, Tremblay P, Michea R, Viau-Guay L, Mérette C, Bouchard R-H, Maziade M, M-A Roy. Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse. Schizophr Res. 2010;118(1-3):285-91.

2009

Cellard C, Tremblay S, Lefèbvre A-A, Laplante L, Achim A, Bouchard R-H, M-A Roy. Insights from the examination of verbal and spatial memory errors in relation to clinical symptoms of patients with recent-onset schizophrenia. Cogn Neuropsychiatry. 2009;14(6):542-58.

2008

Potvin S, Stip E, Lipp O, M-A Roy, Demers M-F, Bouchard R-H, Gendron A. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. Am J Drug Alcohol Abuse. 2008;34(1):75-82.

Potvin S, Kouassi E, Lipp O, Bouchard R-H, M-A Roy, Demers M-F, Gendron A, Astarita G, Piomelli D, Stip E. Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. J Psychopharmacol (Oxford). 2008;22(3):262-9.

2006

Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers M-F, M-A Roy, Bouchard R-H, Gendron A. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin. 2006;22(7):1277-85.

2005

Lehoux C, Lefèbvre A-A, Létourneau K, Viau H, Gosselin D, Szatmari P, Bouchard R-H, Maziade M, M-A Roy. A pilot feasibility study of an extension of the acquaintanceship recruitment procedure in recent-onset psychosis. J Nerv Ment Dis. 2005;193(8):560-3.

2004

Alméras N, Després J-P, Villeneuve J, Demers M-F, M-A Roy, Cadrin C, Mottard J-P, Bouchard R-H. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry. 2004;65(4):557-64.

Poirier S, Bureau V, Lehoux C, Bouchard R-H, Maziade M, Pelletier S, René L, Trépanier J, Emond C, Mérette C, M-A Roy. A factor analysis of the Strauss and Carpenter revised outcome criteria scale: a validation of the French translation. J Nerv Ment Dis. 2004;192(12):864-7.

2003

M-A Roy, Lehoux C, Emond C, Laplante L, Bouchard R-H, Everett J, Mérette C, Maziade M. A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia. Schizophr Res. 2003;62(1-2):155-63.

Participate in
clinical studies

Funding / Support / Partners

© Gouvernement du Québec, 2018